Challenges, Lessons Learned, and Guidance for the Clinical Development of...
It comes as no surprise to any pharmaceutical or biotech company that…
Read Blog Post
How to Comply with the Nitrosamine Regulations for Your New...
Introduction: Are you in the development phase for your medicinal product? Have…
Read Blog Post
ProPharma Group announces the appointment of Bryan Katz as new...
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the…
Read Blog Post
Meet the Expert: Anders Nyholm
Our “Meet the Expert” series introduces you to our team of experts…
Read Blog Post
ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing...
Chicago, IL, September 1, 2022 — ProPharma Group (PPG), the leading global…
Read Blog Post
USP and FDA Propose Updates to Good Storage and Distribution...
Updates have been announced by FDA and for USP <1079>. In this…
Read Blog Post
Meet the Expert: Lucy Radley
Our “Meet the Expert” series introduces you to our team of experts…
Read Blog Post
FDA Announces Availability of Multiple Draft Guidances – Drug Information...
Today, FDA announced the availability of the following draft guidances for industry,…
Read Agency AlertYour Business has Complex Challenges. ProPharma Group has Exceptional Solutions.
We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.
Interested in gaining an industry edge? Let us help you stay up to date.
Sign up to receive updates and industry insights